GBA1-PD showed significant reduction in cerebral glucose metabolism encompassing the medial surface of the frontal cortex and extending to the supplemental motor area (SMA) and cerebral hypo metabolism in the parieto-occipital cortices. Here, GBA1 is linked to Parkinson disease.